Dynamics of Immune Escape during HIV/SIV Infection

Several studies have shown that cytotoxic T lymphocytes (CTLs) play an important role in controlling HIV/SIV infection. Notably, the observation of escape mutants suggests a selective pressure induced by the CTL response. However, it remains difficult to assess the definite role of the cellular immune response. We devise a computational model of HIV/SIV infection having a broad cellular immune response targeting different viral epitopes. The CTL clones are stimulated by viral antigen and interact with the virus population through cytotoxic killing of infected cells. Consequently, the virus population reacts through the acquisition of CTL escape mutations. Our model provides realistic virus dynamics and describes several experimental observations. We postulate that inter-clonal competition and immunodominance may be critical factors determining the sequential emergence of escapes. We show that even though the total killing induced by the CTL response can be high, escape rates against a single CTL clone are often slow and difficult to estimate from infrequent sequence measurements. Finally, our simulations show that a higher degree of immunodominance leads to more frequent escape with a reduced control of viral replication but a substantially impaired replicative capacity of the virus. This result suggests two strategies for vaccine design: Vaccines inducing a broad CTL response should decrease the viral load, whereas vaccines stimulating a narrow but dominant CTL response are likely to induce escape but may dramatically reduce the replicative capacity of the virus.

[1]  Becca Asquith,et al.  Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.

[2]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.

[3]  A. Perelson Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.

[4]  Alessandro Sette,et al.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia , 2000, Nature.

[5]  Sebastian Bonhoeffer,et al.  Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.

[6]  Becca Asquith,et al.  In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques , 2007, Proceedings of the National Academy of Sciences.

[7]  Martin A. Nowak,et al.  Antigenic oscillations and shifting immunodominance in HIV-1 infections , 1995, Nature.

[8]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[9]  Alan S. Perelson,et al.  Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.

[10]  F. A. Seiler,et al.  Numerical Recipes in C: The Art of Scientific Computing , 1989 .

[11]  Rustom Antia,et al.  Mathematical models of cytotoxic T‐lymphocyte killing , 2007, Immunology and cell biology.

[12]  R J D B,et al.  Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .

[13]  R. D. de Boer,et al.  Understanding the Failure of CD8+ T-Cell Vaccination against Simian/Human Immunodeficiency Virus , 2007, Journal of Virology.

[14]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[15]  Sebastian Bonhoeffer,et al.  Stochastic or deterministic: what is the effective population size of HIV-1? , 2006, Trends in microbiology.

[16]  Sebastian Bonhoeffer,et al.  Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.

[17]  Rob J. de Boer,et al.  Understanding the failure of CD8 T-cell vaccination against simian/human immunodeficiency virus , 2007 .

[18]  G. Bocharov,et al.  Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.

[19]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[20]  R. Koup,et al.  Decay Kinetics of Human Immunodeficiency Virus-Specific CD8+ T Cells in Peripheral Blood after Initiation of Highly Active Antiretroviral Therapy , 2001, Journal of Virology.

[21]  Bonaventura Clotet,et al.  HIV-1 Protease Catalytic Efficiency Effects Caused by Random Single Amino Acid Substitutions , 2006, Molecular biology and evolution.

[22]  John Sidney,et al.  Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.

[23]  Alan S. Perelson,et al.  Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.

[24]  Jianhong Cao,et al.  Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection1 , 2003, The Journal of Immunology.

[25]  C. Fernandez,et al.  Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. , 2005, Trends in microbiology.

[26]  Christos J. Petropoulos,et al.  Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus , 2006, The Journal of experimental medicine.

[27]  William H. Press,et al.  The Art of Scientific Computing Second Edition , 1998 .

[28]  Bin Li,et al.  Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution , 2006, Journal of Virology.

[29]  M. Nowak,et al.  Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy , 1999, Journal of Virology.

[30]  D. Nixon,et al.  Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape , 2007, PloS one.

[31]  David C Montefiori,et al.  Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants , 2005, Nature Immunology.

[32]  Katrina Walsh,et al.  Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.

[33]  Philip J. R. Goulder,et al.  Consistent Patterns in the Development and Immunodominance of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ T-Cell Responses following Acute HIV-1 Infection , 2002, Journal of Virology.

[34]  James I Mullins,et al.  Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection. , 2006, Virology.

[35]  Roland R. Regoes,et al.  Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+ T Cells from the Dynamics of Viral Immune Escape , 2007, Journal of Virology.

[36]  Miles P. Davenport,et al.  In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for Macaques , 2007, Journal of Virology.

[37]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[38]  Edward C. Holmes,et al.  Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.

[39]  S. Kent,et al.  Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibody. , 2006, Current HIV research.

[40]  Simon Wain-Hobson Virus Dynamics: Mathematical Principles of Immunology and Virology , 2001, Nature Medicine.

[41]  B. Walker,et al.  Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.

[42]  D. Gillespie Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .

[43]  Todd M. Allen,et al.  Hitting HIV where it hurts: an alternative approach to HIV vaccine design. , 2006, Trends in immunology.

[44]  John F. B. Mitchell,et al.  Quantifying the uncertainty in forecasts of anthropogenic climate change , 2000, Nature.

[45]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[46]  Philip J. R. Goulder,et al.  Compensatory Mutation Partially Restores Fitness and Delays Reversion of Escape Mutation within the Immunodominant HLA-B*5703-Restricted Gag Epitope in Chronic Human Immunodeficiency Virus Type 1 Infection , 2007, Journal of Virology.

[47]  Rob J. De Boer,et al.  Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..

[48]  E. Rosenberg,et al.  Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection , 2001, The Journal of experimental medicine.

[49]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[50]  Marion Cornelissen,et al.  Identification of Sequential Viral Escape Mutants Associated with Altered T-Cell Responses in a Human Immunodeficiency Virus Type 1-Infected Individual , 2003, Journal of Virology.

[51]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[52]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[53]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.